It looks like you never got a proper welcome, Bilz0r, and considering your status in various communities, that's surprising! So, even though you've been editing for a while here's my little contribution, the "official" welcome.
Welcome!
Hello, Bilz0r, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are a few good links for newcomers:
I hope you enjoy editing here and being a Wikipedian! Please sign your name on talk pages using four tildes (~~~~); this will automatically produce your name and the date. If you need help, check out Wikipedia:Where to ask a question, ask me on my talk page, or place {{helpme}} on your talk page and someone will show up shortly to answer your questions. Again, welcome! --Overand16:12, 26 February 2006 (UTC)[reply]
teleology
Noted your comments on the talk page there, which are on target IMO. I may try to edit it although I don't really know that much about the subject, like you, I dropped in to learn about it. Still, nothing like doing something to help one learn it...Cheers, Kaisershatner13:22, 20 July 2007 (UTC)[reply]
Aspirin has been selected as this week's Pharmacology Collaboration of the Week! Please help us bring this article up to featured standards during the week. The goal is to nominate this at WP:FAC on September 10, 2007.
The Wikipedia:WikiProject Pharmacology main page has been updated and overhauled, to make it easier to find things, as well as to highlight other goals and announcements for the project.
Fvasconcellos notes that discussion is ongoing regarding the current wording of MEDMOS on including dosage information in drug articles. All input is welcome.
Here's a brief update in some of the recent developments of WikiProject Pharmacology!
Aspirin has just completed its two week run as the first Collaboration of the Week! Many thanks to those editors that contributed; the article got a lot of good work accomplished, and in particular, much work was done in fixing up the history section. It's still not quite "done" yet (is a wikipedia article really ever done?), but after two weeks I think it's more important to push onwards with the development of the new collaboration of the week program. I will be fixing up Aspirin in the next few days and possibly nominating it for either GA or FA status.
Muscle relaxant has been selected as the new Collaboration of the week until October 2, 2007! This article is currently rated as a "stub", so it's got quite a bit of work cut out for collaborators! Admittedly, featured status could be a long way off,... but still attainable! At the least, maybe we could at least get it up to meeting the Good article criteria? Please stop by the article and help improve it.
Resveratrol, having recently achieved GA status on August 16, 2007, is now making a run for featured status. This is quite a fascinating compound. If you can, please stop by its discussion page and leave comments in support of it.
Please remember that Wikipedia is not a forum for discussing or dispensing medical advice amongst users. Specifically, talk pages of articles should only be used to discuss improving the actual article in question. To help alleviate this situation, the template {{talkheader}} may be added to the top of talk pages, reminding users of the purpose of such pages. Additionally, unsigned comments and comments by anonymous users that are inappropriate may be removed from talk pages without being considered vandalism.
I reverted your edit to the article's lead because it did not make sense. First, you started by going into injuries, inflammation and many diseases of the nervous system, instead of defining the main subject, with the title of the article in bold in that sentence (this is actually part of the manual of style). Second, your text only covers the spasmolytics, and doesn't introduce the other of the two major types of muscle relaxant drugs, neuromuscular blockers, so it was incomplete. Dr. Cash21:47, 19 September 2007 (UTC)[reply]
I am not familiar with Rang Dale and Ritter's Pharmacology books, so I can't verify their content. I am checking two sources on this, both book sources:
Basic & Clinical Pharmacology by Betram G. Katzung (7th Edition, 1998) ISBN 083505651.
Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th Edition, 1996); Eds. Joel G. Hardman & Lee E. Limbird. ISBN0070262667.
Both sources seem to be in agreement regarding neuromuscular blockers; In the index of Goodman & Gilman's, in fact, I look up 'muscle relaxant' and it says 'see neuromuscular blocking agents'.
Drugs don't necessarily have to have gone through extensive clinical trials to be considered drugs in a particular class - many early drugs developed in the first half of the 20th century, or before, very likely did not go through clinical trials like they do today. Plus, through the natural evolution of things, an early drug is very likely to have been replaced by a newer drug with a slightly different, yet better, mechanism. That's no reason to completely remove that drug from the class entirely.
Furthermore, I don't think the article on muscle relaxants should be comprised primarily of main sections of individual drugs of the whole class. That's going to get way too long, and it won't really help a reader's understanding of what a muscle relaxant does. We need to define the class, and the overall mechanisms of action and pharmacology, and then provide a couple of examples of such agents within the text itself, not as major sections. Dr. Cash22:55, 19 September 2007 (UTC)[reply]
The Pharmacology Collaboration of the Week has been changed to Collaboration of the Month, based on current participation levels. It is also more likely that articles collaborated on for one month are more likely to achieve featured quality than articles worked on for only a week or two.
Parafon Forte a candidate for the Pharmacology Collaboration of the Month. Please click here to support or comment on the nomination. You are getting this message as a WikiProject Pharmacology Member
Hello, I noticed that you added the Society for Neuroscience user box to your page, and I just wanted to say, from one electrophysiologist to another, welcome aboard! --Tryptofish (talk) 17:19, 6 April 2010 (UTC)[reply]
The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)
Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.
Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!
If you are stil active as a medical editor, come and sign up :)
